BridgeBio Pharma (BBIO) News Today $52.86 -0.42 (-0.79%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$52.32 -0.55 (-1.03%) As of 10/3/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period BridgeBio Pharma (BBIO) Is Up 5.6% After Acoramidis Shows Broad ATTR-CM Benefit in Phase 3 Data3 hours ago | finance.yahoo.comBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)October 3 at 4:01 PM | globenewswire.comPlatinum Investment Management Ltd. Grows Position in BridgeBio Pharma, Inc. $BBIOOctober 2 at 6:35 AM | marketbeat.comUBS Reaffirms Buy on BridgeBio (BBIO) With Optimism Around Attruby LaunchOctober 2 at 5:49 AM | msn.comBridgeBio Pharma, Inc. (BBIO) Presents at HFSA 2025 - SlideshowSeptember 30, 2025 | seekingalpha.comBridgeBio's Acoramidis Cuts Risk Within Weeks In Rare Heart ConditionSeptember 29, 2025 | finance.yahoo.comBridgeBio's Acoramidis Cuts Risk Within Weeks In Rare Heart ConditionSeptember 29, 2025 | benzinga.comBridgeBio Pharma, Inc.: Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CMSeptember 29, 2025 | finanznachrichten.deBridgeBio Pharma, Inc.: Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CMSeptember 29, 2025 | finanznachrichten.deMoss Adams Wealth Advisors LLC Has $1.04 Million Stock Position in BridgeBio Pharma, Inc. $BBIOSeptember 29, 2025 | marketbeat.comAcoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CMSeptember 28, 2025 | globenewswire.comCritical Comparison: Targeted Medical Pharma (OTCMKTS:TRGM) versus BridgeBio Pharma (NASDAQ:BBIO)September 27, 2025 | americanbankingnews.comAnalyzing Globeimmune (OTCMKTS:GBIM) and BridgeBio Pharma (NASDAQ:BBIO)September 26, 2025 | americanbankingnews.comBridgeBio Pharma’s Encaleret Shows Positive Phase 2 Results, Normalizes Calcium in Post-Surgical HypoparathyroidismSeptember 24, 2025 | msn.comRetirement Income Solutions Inc Acquires Shares of 5,000 BridgeBio Pharma, Inc. $BBIOSeptember 24, 2025 | marketbeat.comH.C. Wainwright Reiterates a Buy on BridgeBio Pharma (BBIO)September 24, 2025 | insidermonkey.comAssenagon Asset Management S.A. Has $15.13 Million Stake in BridgeBio Pharma, Inc. $BBIOSeptember 23, 2025 | marketbeat.comStrs Ohio Makes New Investment in BridgeBio Pharma, Inc. $BBIOSeptember 23, 2025 | marketbeat.comBridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025September 22, 2025 | globenewswire.comAtle Fund Management AB Buys 14,132 Shares of BridgeBio Pharma, Inc. $BBIOSeptember 21, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.September 17, 2025 | marketbeat.comIntech Investment Management LLC Purchases 7,877 Shares of BridgeBio Pharma, Inc. $BBIOSeptember 17, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for BridgeBio Pharma (NASDAQ:BBIO)September 16, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Rating of "Buy" from AnalystsSeptember 15, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $82.00September 14, 2025 | marketbeat.comBridgeBio Pharma (BBIO) Gets a Buy from Piper SandlerSeptember 12, 2025 | theglobeandmail.comPfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: BloombergSeptember 12, 2025 | msn.comFred Alger Management LLC Invests $982,000 in BridgeBio Pharma, Inc. $BBIOSeptember 12, 2025 | marketbeat.comWoodline Partners LP Trims Holdings in BridgeBio Pharma, Inc. $BBIOSeptember 11, 2025 | marketbeat.comZimmer Partners LP Has $10.42 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIOSeptember 11, 2025 | marketbeat.comBridgeBio Pharma, Inc. $BBIO Stock Position Cut by Exome Asset Management LLCSeptember 11, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 SharesSeptember 10, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Director Sells $3,933,840.00 in StockSeptember 10, 2025 | marketbeat.comBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)September 10, 2025 | globenewswire.comBridgeBio Pharma, Inc. (BBIO) Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar Call (Transcript)September 10, 2025 | seekingalpha.comAutosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar PresentationSeptember 10, 2025 | seekingalpha.comBaird Financial Group Inc. Purchases New Position in BridgeBio Pharma, Inc. $BBIOSeptember 10, 2025 | marketbeat.comNeil Kumar Sells 40,000 Shares of BridgeBio Pharma (NASDAQ:BBIO) StockSeptember 9, 2025 | insidertrades.comBridgeBio Pharma, Inc. (BBIO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comBridgeBio Pharma (BBIO): Assessing Valuation After Strong Encaleret Data and Pipeline AdvancesSeptember 8, 2025 | finance.yahoo.comPhilosophy Capital Management LLC Takes $13.54 Million Position in BridgeBio Pharma, Inc. $BBIOSeptember 8, 2025 | marketbeat.comAlliancebernstein L.P. Trims Stock Position in BridgeBio Pharma, Inc. $BBIOSeptember 8, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Acquires 246,555 Shares of BridgeBio Pharma, Inc. $BBIOSeptember 8, 2025 | marketbeat.comBridgeBio announces results from Phase 2 study of encaleretSeptember 7, 2025 | msn.comBosun Asset Management LLC Takes Position in BridgeBio Pharma, Inc. $BBIOSeptember 7, 2025 | marketbeat.comEncaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical HypoparathyroidismSeptember 6, 2025 | globenewswire.comDuquesne Family Office LLC Purchases Shares of 438,050 BridgeBio Pharma, Inc. $BBIOSeptember 6, 2025 | marketbeat.comBridgeBio Pharma, Inc. $BBIO Shares Bought by Cormorant Asset Management LPSeptember 6, 2025 | marketbeat.comBridgeBio Pharma, Inc. $BBIO Shares Sold by Cutter Capital Management LPSeptember 6, 2025 | marketbeat.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) StockSeptember 5, 2025 | marketbeat.com Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBIO Media Mentions By Week BBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.360.53▲Average Medical News Sentiment BBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼1010▲BBIO Articles Average Week Get the Latest News and Ratings for BBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BeOne Medicines News Insmed News BioNTech News Teva Pharmaceutical Industries News Genmab A/S News Summit Therapeutics News Dr. Reddy's Laboratories News Ascendis Pharma A/S News Viatris News Roivant Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredThese financial titans stride the earth, invisibleUBS says millionaire ranks have surged 5-fold — but many of these new millionaires aren’t tech moguls or Wall ...Porter & Company | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
